Pharsight

Braintree patents expiration

1. Axid patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6930119 BRAINTREE Liquid pharmaceutical composition
Jul, 2022

(1 year, 9 months ago)

Drugs and Companies using NIZATIDINE ingredient

Market Authorisation Date: 25 May, 2004

Treatment: NA

Dosage: SOLUTION;ORAL

How can I launch a generic of AXID before it's drug patent expiration?
More Information on Dosage

AXID family patents

Family Patents

2. Halflytely patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7291324 BRAINTREE Method of bowel cleansing
Oct, 2022

(1 year, 5 months ago)

Drug Exclusivity Drug Exclusivity Expiration
New Product(NP) Jul 16, 2013

Drugs and Companies using BISACODYL; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE ingredient

Market Authorisation Date: 24 September, 2007

Treatment: Gastrointestinal lavage indicated for cleansing of the colon as a preparation for colonoscopy in adults

Dosage: FOR SOLUTION, TABLET, DELAYED RELEASE;ORAL

More Information on Dosage

HALFLYTELY family patents

Family Patents